SCHEMBL3500923

SCHEMBL3500923

NC1CCCCC1(N)[Pt]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5870436 1.00
SCHEMBL4018597 1.00
Sulfuric Acid SCHEMBL11494938 0.87
Oxalic Acid SCHEMBL3264634 0.87
Glycolic Acid SCHEMBL10953166 0.82 USP2 (0.32)
SCHEMBL8939302 0.80
SCHEMBL1155589 0.72 THRB (0.35)
SCHEMBL473092 0.72
SCHEMBL22169227 0.72
SCHEMBL23358875 0.70 THRB (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116173231-A Antitumor platinum drug nano-composite and preparation method and application thereof 浙江大学杭州国际科创中心 2023-05-30 CN claimed
CN-114746124-A Delivery system complexes comprising active agent precipitates and methods of use 北卡罗来纳-查佩尔山大学 2022-07-12 CN claimed
CN-106237340-B Application of hyaluronic acid nanoparticles in preparation of medicine for treating lymphatic system tumor 财团法人工业技术研究院 2020-09-08 CN claimed
CN-106957340-A A kind of synthetic method of oxaliplatin 荆楚理工学院 2017-07-18 CN claimed
CN-106237340-A Application of hyaluronic acid nanoparticles in preparation of medicine for treating lymphatic system tumor 财团法人工业技术研究院 2016-12-21 CN claimed
US-9289510-B2 Polymeric drug delivery conjugates and methods of making and using thereof UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-03-22 US claimed
JP-2787241-B2 1998-08-13 JP claimed
EP-0419535-A4 PLATINUM-POLYMER COMPLEXES AND THEIR USE AS ANTITUMOR AGENTS 1993-02-24 EP claimed
EP-0419535-A1 PLATINUM-POLYMER COMPLEXES AND THEIR USE AS ANTITUMOR AGENTS. ANDRULIS RES CORP (US) 1991-04-03 EP claimed
US-4931553-A PLATINUM-AMINE COMPLEX LINKED TO BIOSTABLE ANIONIC POLYMERS; BIODEGRADABLE OR STABLE, BIOCOMPATIBLE ANDRULIS PHARMACEUTICALS CORPORATION 1990-06-05 US claimed
WO-1989010928-A1 PLATINUM-POLYMER COMPLEXES AND THEIR USE AS ANTITUMOR AGENTS ANDRULIS RESEARCH CORPORATION (US) 1989-11-16 WO claimed
US-4853380-A REACTING SULFONATED HETEROCYCLIC SULFUR COMPOUNDS WITH DIAMINES OF PLATINUM NITRATE INTERNATIONAL PHARMACEUTICAL PRODUCTS (US) 1989-08-01 US claimed
JP-58124797-A None JP disclosed
JP-64000094-A None JP disclosed
JP-10142215-A None JP disclosed
JP-64000093-A None JP disclosed
JP-S58124797-A NOVEL 1,2-CYCLOHEXANEDIAMINE PLATINUM COMPLEX SHIONOGI & CO LTD 1983-07-25 JP disclosed
US-4284579-A ANTITUMOUR AGENTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 1981-08-18 US disclosed
EP-0026813-A2 (N-phosphonoacetyl-L-aspartato) (1,2 diaminocyclohexane) platinum (II) and the sodium, potassium or lithium salts thereof, their preparation and pharmaceutical compositions containing them THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) 1981-04-15 EP disclosed
WO-1981000256-A1 (N-PHOSPHONACETYL-L-ASPARTATO)(1,2-DIAMINOCYCLOHEXANE)-PLATINUM(II)OR ALKALI METAL SALT US COMMERCE (US) 1981-02-05 WO disclosed